168 related articles for article (PubMed ID: 18220039)
1. [Administration of rituximab in rheumatoid arthritis from the position of evidence-based medicine].
Nasonov EL
Ter Arkh; 2007; 79(12):76-82. PubMed ID: 18220039
[No Abstract] [Full Text] [Related]
2. Use of rituximab for the treatment of rheumatoid arthritis: the Latin American context.
Soriano ER; Galarza-Maldonado C; Cardiel MH; Pons-Estel BA; Massardo L; Caballero-Uribe CV; Achurra-Castillo AF; Barile-Fabris LA; Chávez-Corrales J; Díaz-Coto JF; Esteva-Spinetti MH; Guibert-Toledano M; Palazuelos FI; Keiserman MW; Lomonte AV; Mota LM; Pineda Villaseñor C; Alarcón GS;
Rheumatology (Oxford); 2008 Jul; 47(7):1097-9. PubMed ID: 18463144
[No Abstract] [Full Text] [Related]
3. [Rituximab (Mabthera)--new approach in treatment of rheumatoid arthritis].
Anić B
Reumatizam; 2007; 54(2):72-3. PubMed ID: 18351146
[No Abstract] [Full Text] [Related]
4. Treatment of rheumatoid arthritis: strategies for achieving optimal outcomes.
Gibofsky A; Yazici Y
Ann Rheum Dis; 2010 Jun; 69(6):941-2. PubMed ID: 20498219
[No Abstract] [Full Text] [Related]
5. Clinical outcome and B cell depletion in patients with rheumatoid arthritis receiving rituximab monotherapy in comparison with patients receiving concomitant methotrexate.
Owczarczyk K; Hellmann M; Fliedner G; Röhrs T; Maizus K; Passon D; Hallek M; Rubbert A
Ann Rheum Dis; 2008 Nov; 67(11):1648-9. PubMed ID: 18854518
[No Abstract] [Full Text] [Related]
6. Rituximab for rheumatoid arthritis. Practical guidance for optimizing treatment.
Furfaro N
Adv Nurse Pract; 2008 Jan; 16(1):61-4. PubMed ID: 20014746
[No Abstract] [Full Text] [Related]
7. [Rituximab: a new therapeutic arm in refractory rheumatoid arthritis: about one case].
Abdelmoula LC; Testouri N; Ben Hadj Yahia C; Tekaya R; Ben M'barek R; Chaabouni L; Zouari R
Tunis Med; 2008 Sep; 86(9):841-2. PubMed ID: 19472790
[No Abstract] [Full Text] [Related]
8. Successful treatment of rheumatoid vasculitis-associated cutaneous ulcers using rituximab in two patients with rheumatoid arthritis.
Hellmann M; Jung N; Owczarczyk K; Hallek M; Rubbert A
Rheumatology (Oxford); 2008 Jun; 47(6):929-30. PubMed ID: 18411212
[No Abstract] [Full Text] [Related]
9. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
Koumakis E; Wipff J; Avouac J; Kahan A; Allanore Y
J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227
[No Abstract] [Full Text] [Related]
10. A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis.
van den Bemt BJ; Vos K; den Broeder AA; Blom M; Thurlings RM; Bartelds GM; Stapel SO; Barrera P; Tak PP; Nurmohamed MT; Wolbink GJ
Ann Rheum Dis; 2009 Aug; 68(8):1368-9. PubMed ID: 19605744
[No Abstract] [Full Text] [Related]
11. Use of biologic agents in rheumatoid arthritis: introduction.
Silman AJ
Rheumatology (Oxford); 2011 Sep; 50 Suppl 4():iv3-4. PubMed ID: 21859703
[No Abstract] [Full Text] [Related]
12. Successful treatment of rheumatoid vasculitis-associated foot drop with rituximab.
Maher LV; Wilson JG
Rheumatology (Oxford); 2006 Nov; 45(11):1450-1. PubMed ID: 16936329
[No Abstract] [Full Text] [Related]
13. Long term treatment of rheumatoid arthritis with rituximab.
Caporali R; Caprioli M; Bobbio-Pallavicini F; Bugatti S; Montecucco C
Autoimmun Rev; 2009 Jun; 8(7):591-4. PubMed ID: 19393205
[TBL] [Abstract][Full Text] [Related]
14. Rituximab in rheumatoid arthritis following anti-TNF-associated tuberculosis.
Burr ML; Malaviya AP; Gaston JH; Carmichael AJ; Ostör AJ
Rheumatology (Oxford); 2008 May; 47(5):738-9. PubMed ID: 18375402
[No Abstract] [Full Text] [Related]
15. Membranous glomerulopathy associated with rheumatoid arthritis may respond to rituximab.
Pixley J; Wolf B; O'Neill W
Scand J Rheumatol; 2008; 37(4):313-4. PubMed ID: 18612934
[No Abstract] [Full Text] [Related]
16. Costs of rituximab maintenance treatment in patients with refractory rheumatoid arthritis.
Risselada A; Tekstra J; Teng YK; Welsing PM; Breedveld F; van Laar JM; Bijlsma JW
Ann Rheum Dis; 2010 Oct; 69(10):1891-2. PubMed ID: 20444758
[No Abstract] [Full Text] [Related]
17. Safety of combination therapy with rituximab and etanercept for patients with rheumatoid arthritis.
Blank N; Max R; Schiller M; Briem S; Lorenz HM
Rheumatology (Oxford); 2009 Apr; 48(4):440-1. PubMed ID: 19153143
[No Abstract] [Full Text] [Related]
18. Comparative overview of safety of the biologics in rheumatoid arthritis.
Khraishi M
J Rheumatol Suppl; 2009 Jun; 82():25-32. PubMed ID: 19509327
[TBL] [Abstract][Full Text] [Related]
19. Response to the commentary 'Pooled indices to measure rheumatoid arthritis activity: a good reflection of the physician's mind'.
Vander Cruyssen B; Durez P; Westhovens R; Vastesaeger N; Geldhof A; De Keyser F
Arthritis Res Ther; 2006; 8(6):406. PubMed ID: 17049071
[No Abstract] [Full Text] [Related]
20. B cell depletion in early rheumatoid arthritis: a new concept in therapeutics.
Renato GM
Ann N Y Acad Sci; 2009 Sep; 1173():729-35. PubMed ID: 19758222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
